Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):330–337. doi: 10.1097/QAI.0000000000001503

Figure 1.

Figure 1

Flow diagram of MTN-020/ASPIRE real time adherence monitoring system1,2

1 Orange represents the clinical sites, blue represents the data center, green represents the core laboratory, yellow represents the pharmacology testing laboratory, and purple represents the MTN-020/ASPIRE study leadership team.

2 Solid lines indicate that study blinding, defined as the identification of the linkage of participant identifiers (IDs) to the randomization arm, is upheld by staff for the organizations indicated by the color of the box. Small dashed lines indicate that randomization assignments are linked by participant ID so therefore staff are unblinded to the randomization assignment by participant ID. Large dashed lines indicate that the randomization arm may be deduced based on levels of blood plasma found through dapivirine test results so therefore staff were considered partially blinded to the randomization assignment.